The results obtained with curcumin in this study suggest several novel approaches to achieve a more effective therapy for rhabdomyosarcoma by targeting AKT-mTOR, AMPK, STAT, and mutant p53. The gene discussed is AKT1; the disease is rhabdomyosarcoma.